|COVID–19 NEWS||Japan registers record 250,403 COVID-19 cases within past 24 hours | COVID: Malaysia records increase in new cases, fatalities - Dr Noor Hisham | New COVID-19 cases drop 5.2 pct last week - Health Dg | Witness still COVID-19 positive, Ahmad Zahid's corruption trial postponed | Japan's daily COVID cases top 180,000, set fresh record amid 7th wave ||
KUALA LUMPUR, Nov 30 -- The Malaysia Automotive, Robotics and IOT Institute (MARii) and the Institute for Medical Research (IMR) have successfully enhanced the efficiency of sample preparation of the ImmuSAFE COVID+ Biochip Test through its upgraded laboratory.
MARii chief executive officer Datuk Madani Sahari said the laboratory, called MARii ImmuSAFE Smart Automation Line (SAL), improves the ImmuSAFE sample preparation process by the utilisation of autonomous robots, intelligent monitoring systems, and big data analytics developed through MARii.
He said these systems improve the speed and accuracy of liquid handling during incubation, dilution, washing, and scanning of samples, which are essential components of the test that have been subject to bottlenecks in previous versions of the process.
“Many of the technologies and design approaches used to improve the ImmuSAFE process came from the principles utilised in the mobility sector, an important focus of MARii.
“We are extremely happy that the same approaches have been utilised today in the bio-medical sector, and we hope more sectors can benefit from the numerous technologies developed through MARii and our parent ministry, the Ministry of International Trade and Industry,” he said in a statement today.
Madani said all processes within the laboratory are monitored through the MARii SAL dashboard, which tracks the progress of each sample and provides a snapshot of daily targets, machine outputs, planned versus actual progress, quality performance, and operational efficiency in real time.
SAL laboratory is located in IMR’s laboratories in Setia Alam, Selangor.
ImmuSAFE is the world’s first lab-based, multi-antigen and multi-domain COVID-19 serology test, developed between MARii, IMR, and Sengenics.
Bernama is the trusted source of reliable real-time comprehensive and accurate news for both the public and media practitioners. Our news is published at www.bernama.com ; BERNAMA TV on: Astro Channel 502, unifi TV Channel 631, MYTV Channel 121 IFLIX; and Bernama Radio broadcasting locally on FM93.9 in Klang Valley, Johor (FM107.5), Kota Kinabalu (FM107.9) and Kuching (FM100.9).
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial